NCT02020486View on ClinicalTrials.gov

A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy
Interventions
DRUG

Perampanel

2 mg up to 4 mg

DRUG

Perampanel

2 mg up to 6 mg

Trial Locations (1)

Unknown

Inje University Busan Paik Hospital, Busan

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02020486 - A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects | Biotech Hunter | Biotech Hunter